Naya Biosciences postpones 2024 annual meeting to April 9, 2025; all prior votes void

INVO Fertility, Inc.

Annual meeting postponed from March 10 to April 9, 2025; new record date set for March 10, 2025.
Standard proposals (director election, auditor ratification) have sufficient votes; special proposals (share issuance, plan amendment, authorized shares) lack required votes.
All votes cast under the February proxy are null and void; new proxy card will be issued.
Nasdaq granted extension until June 30, 2025 to regain compliance with annual meeting rule.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.